Prediction Case File
YouTubeEvaluation Complete

Friends! In This Video Im going to Analyze the Magnificent 7 Stocks.

7 extracted signals · 7 resolved · 0 still active

The Patient Investor profile imageThe Patient InvestorIndependent analyst profile
Source published
07 Sept 2025, 17:18 UTC
Recorded by Tahlil Plus
18 May 2026, 20:23 UTC
Video preview for Friends! In This Video Im going to Analyze the Magnificent 7 Stocks.
Source overview

AI-generated source summary

The video provides a fundamental analysis of the Magnificent Seven stocks, giving an inferred fair value. Google is likely to grow 12-13% annually without multiple expansion, with a Google Cloud growth rate of 31%. The speaker likes Amazon and expects cloud to double. However, Amazon's cash flow is decelerating and its growth is around 17%. Meta is trading at 26.5 times earnings, and the analysis mentions this. Microsoft is overvalued based on analyst estimates; 421-481 is considered as a fair valuation entry point for it. A valuation is given with a timeframe, although a general one.

AI-generated summary based on the source content.

Live evaluation

Signal outcomes at a glance

Evaluation Complete
Signals
7
Extracted from this source
Open
0
Still being tracked
Successful
2
Resolved successfully
Failed
5
Resolved unsuccessfully
Other
0
Cancelled, invalid or excluded
Resolved success
28.57%
7 resolved; open signals omitted
Extracted intelligence

Signals in this source

Case timeline

Evidence and evaluation progress

  1. Original source published

    The analyst published the original source item.

  2. First prediction resolved

    The first evaluable outcome in this case reached a terminal result.

  3. Source recorded by Tahlil Plus

    The public source was preserved as the evidence record for this case.

  4. Market predictions extracted

    7 eligible signals linked to this case.

  5. Outcome tracking started

    Tahlil Plus began monitoring the extracted predictions.

  6. Case evaluation completed

    All evaluable predictions in this case reached terminal outcomes.

Analyst snapshot

The Patient Investor

Platform-wide history, separate from this source evaluation.

Reliability
47.9
Tracked signals
355
Historical success
34.9%
View full analyst profile →
Methodology & disclosure

Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.

Continue the evidence trail